Biotrend Cevre ve Enerji Yatirimlari A.S. (IST: BIOEN)
Turkey
· Delayed Price · Currency is TRY 15.34
-0.04 (-0.26%)
Jan 23, 2025, 5:25 PM GMT+3
IST: BIOEN Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 1,845 | 2,233 | 2,338 | 427.7 | 245.3 | 92.06 | Upgrade
|
| Revenue Growth (YoY) | -52.02% | -4.48% | 446.57% | 74.36% | 166.47% | 87.02% | Upgrade
|
| Operations & Maintenance | 34.77 | 48.14 | 50.97 | 10.27 | 6.77 | 2.69 | Upgrade
|
| Selling, General & Admin | 458.35 | 325.19 | 249.27 | 42.47 | 21.94 | 8.32 | Upgrade
|
| Other Operating Expenses | 1,701 | 1,826 | 1,486 | 286.45 | 173.43 | 58.04 | Upgrade
|
| Total Operating Expenses | 2,194 | 2,199 | 1,787 | 339.19 | 202.14 | 69.05 | Upgrade
|
| Operating Income | -348.78 | 34.05 | 551.03 | 88.51 | 43.16 | 23.01 | Upgrade
|
| Interest Expense | -441.39 | -350.19 | -106.86 | -31.55 | -14.16 | -11.9 | Upgrade
|
| Interest Income | 297.62 | 85.51 | 15.9 | 25.71 | 28.47 | 3.56 | Upgrade
|
| Net Interest Expense | -143.77 | -264.68 | -90.96 | -5.84 | 14.31 | -8.34 | Upgrade
|
| Income (Loss) on Equity Investments | 67.73 | 98.48 | 41.05 | 25.74 | 11.14 | -1.44 | Upgrade
|
| Currency Exchange Gain (Loss) | -212.31 | 76.12 | -272.02 | -77.32 | -1.16 | -6.21 | Upgrade
|
| Other Non-Operating Income (Expenses) | 695.69 | 987.02 | 463.03 | -2.46 | -3.11 | -0.63 | Upgrade
|
| EBT Excluding Unusual Items | 58.56 | 930.99 | 692.13 | 28.64 | 64.35 | 6.39 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.53 | -8.41 | - | - | -0.68 | -0 | Upgrade
|
| Insurance Settlements | - | - | - | - | - | 0.05 | Upgrade
|
| Legal Settlements | -1.01 | 5.52 | -6.85 | -5.22 | -4.24 | - | Upgrade
|
| Pretax Income | 58.08 | 928.1 | 685.28 | 23.42 | 59.42 | 6.43 | Upgrade
|
| Income Tax Expense | -445.75 | -22.02 | 108.73 | 19.43 | 9.5 | 3.68 | Upgrade
|
| Earnings From Continuing Ops. | 503.83 | 950.11 | 576.56 | 4 | 49.92 | 2.75 | Upgrade
|
| Minority Interest in Earnings | -10.14 | -1.99 | 0.2 | 2.55 | 0.55 | 2.93 | Upgrade
|
| Net Income | 493.69 | 948.12 | 576.76 | 6.54 | 50.47 | 5.68 | Upgrade
|
| Net Income to Common | 493.69 | 948.12 | 576.76 | 6.54 | 50.47 | 5.68 | Upgrade
|
| Net Income Growth | -57.87% | 64.39% | 8716.24% | -87.04% | 788.28% | - | Upgrade
|
| Shares Outstanding (Basic) | 500 | 500 | 500 | 500 | 427 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 500 | 500 | 500 | 500 | 427 | 4 | Upgrade
|
| Shares Change (YoY) | - | - | - | 17.19% | 11030.44% | - | Upgrade
|
| EPS (Basic) | 0.99 | 1.90 | 1.15 | 0.01 | 0.12 | 1.48 | Upgrade
|
| EPS (Diluted) | 0.99 | 1.90 | 1.15 | 0.01 | 0.12 | 1.48 | Upgrade
|
| EPS Growth | -57.87% | 64.39% | 8716.25% | -88.94% | -92.02% | - | Upgrade
|
| Free Cash Flow | 1,212 | 69.58 | -354.09 | -767.25 | -234.14 | -47.79 | Upgrade
|
| Free Cash Flow Per Share | 2.42 | 0.14 | -0.71 | -1.53 | -0.55 | -12.47 | Upgrade
|
| Profit Margin | 26.75% | 42.46% | 24.67% | 1.53% | 20.58% | 6.17% | Upgrade
|
| Free Cash Flow Margin | 65.68% | 3.12% | -15.15% | -179.39% | -95.45% | -51.91% | Upgrade
|
| EBITDA | 52.95 | 420.48 | 831.54 | 119.87 | 64.59 | 36.26 | Upgrade
|
| EBITDA Margin | 2.87% | 18.83% | 35.57% | 28.03% | 26.33% | 39.39% | Upgrade
|
| D&A For EBITDA | 401.73 | 386.43 | 280.5 | 31.35 | 21.43 | 13.25 | Upgrade
|
| EBIT | -348.78 | 34.05 | 551.03 | 88.51 | 43.16 | 23.01 | Upgrade
|
| EBIT Margin | -18.90% | 1.52% | 23.57% | 20.70% | 17.60% | 24.99% | Upgrade
|
| Effective Tax Rate | - | - | 15.87% | 82.94% | 15.98% | 57.28% | Upgrade
|
Source: S&P Capital IQ. Utility template. Financial Sources.